SELNET clinical practice guidelines for bone sarcoma

J. Y. Blay; E. Palmerini; J. Bollard; S. Aguiar; M. Angel; B. Araya; R. Badilla; D. Bernabeu; F. Campos; Caro-Sánchez Chs; A. Carvajal Montoya; S. Casavilca-Zambrano; Castro-Oliden 5th; M. Chacón; M. A. Clara-Altamirano; P. Collini; R. Correa Genoroso; F. D. Costa; M. Cuellar; A. P. Dei Tos; H. R. Dominguez Malagon; D. M. Donati; A. Dufresne; M. Eriksson; M. Farias-Loza; A. M. Frezza; T. Frisoni; D. Y. Garcia-Ortega; H. Gerderblom; F. Gouin; M. C. Gómez-Mateo; A. Gronchi; J. Haro; N. Hindi; L. Huanca; N. Jimenez; M. Karanian; B. Kasper; A. Lopes; B. B. Lopes David; A. Lopez-Pousa; G. Lutter; R. G. Maki; H. Martinez-Said; J. L. Martinez-Tlahuel; C. A. Mello; J. M. Morales Pérez; D. S. Moura; S. A. Nakagawa; A. G. Nascimento; E. J. Ortiz-Cruz; S. Patel; Y. Pfluger; S. Provenzano; A. Righi; A. Rodriguez; T. G. Santos; K. Scotlandi; Silva Mlg; T. Soulé; S. Stacchiotti; C. M. Valverde; F. Waisberg; E. Zamora Estrada; J. Martin-Broto

doi:10.1016/j.critrevonc.2022.103685

Back

SELNET clinical practice guidelines for bone sarcoma

Journal article

Open access

Peer reviewed

SELNET clinical practice guidelines for bone sarcoma

J. Y. Blay, E. Palmerini, J. Bollard, S. Aguiar, M. Angel, B. Araya, R. Badilla, D. Bernabeu, F. Campos, Caro-Sánchez Chs, …

Critical reviews in oncology/hematology, Vol.174, p.103685

2022

DOI: https://doi.org/10.1016/j.critrevonc.2022.103685

PMID: 35460913

Appears in Miller School of Medicine - Latest Publications

Abstract

Adult

Bone Neoplasms/diagnosis/pathology/therapy

Humans

Osteosarcoma/diagnosis/pathology/therapy

Practice Guidelines as Topic

Sarcoma/diagnosis/pathology/therapy

Soft Tissue Neoplasms/pathology

Bone sarcoma

Clinical guidelines

Latin-America context

Bone sarcoma are infrequent diseases, representing < 0.2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. This approach leads to an improvement in patient's outcome, as demonstrated in several studies. The Sarcoma European Latin-American Network (SELNET), aims to improve clinical outcome in sarcoma care, with a special focus in Latin-American countries. These Clinical Practice Guidelines (CPG) have been developed and agreed by a multidisciplinary expert group (including medical and radiation oncologist, surgical oncologist, orthopaedic surgeons, radiologist, pathologist, molecular biologist and representatives of patients advocacy groups) of the SELNET consortium, and are conceived to provide the standard approach to diagnosis, treatment and follow-up of bone sarcoma patients in the Latin-American context.

Files and links (1)

url

https://doi.org/10.1016/j.critrevonc.2022.103685View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: SELNET clinical practice guidelines for bone sarcoma
Creators: J. Y. Blay - Centre Léon Bérard
E. Palmerini - Istituto Ortopedico Rizzoli
J. Bollard - Centre Léon Bérard
S. Aguiar - AC Camargo Hospital
M. Angel - Instituto Alexander Fleming
B. Araya - Ministerio de Agricultura y Ganadería de Costa Rica
R. Badilla - Ministerio de Agricultura y Ganadería de Costa Rica
D. Bernabeu - Hospital Universitario La Paz
F. Campos
Caro-Sánchez Chs
A. Carvajal Montoya
S. Casavilca-Zambrano - Instituto Nacional de Enfermedades Neoplásicas
Castro-Oliden 5th
M. Chacón - Instituto Alexander Fleming
M. A. Clara-Altamirano - Instituto Nacional de Cancerología
P. Collini - Fondazione IRCCS Istituto Nazionale dei Tumori
R. Correa Genoroso
F. D. Costa - AC Camargo Hospital
M. Cuellar - Instituto Nacional de Cancerología
A. P. Dei Tos
H. R. Dominguez Malagon
D. M. Donati - Istituto Ortopedico Rizzoli
A. Dufresne - Centre Léon Bérard
M. Eriksson - Instituto Nacional de Cancerología
M. Farias-Loza - Instituto Nacional de Cancerología
A. M. Frezza - Instituto Nacional de Cancerología
T. Frisoni - University of Padua
D. Y. Garcia-Ortega
H. Gerderblom - Instituto Alexander Fleming
F. Gouin - AC Camargo Hospital
M. C. Gómez-Mateo - Instituto Nacional de Cancerología
A. Gronchi - Fondazione IRCCS Istituto Nazionale dei Tumori
J. Haro
N. Hindi - Hospital Clínico Universitario Virgen de la Victoria
L. Huanca - Instituto Nacional de Cancerología
N. Jimenez - Hospital Clínico Universitario Virgen de la Victoria
M. Karanian - Instituto Nacional de Cancerología
B. Kasper - Instituto Nacional de Enfermedades Neoplásicas
A. Lopes - Fondazione IRCCS Istituto Nazionale dei Tumori
B. B. Lopes David
A. Lopez-Pousa
G. Lutter - Hospital Clínico Universitario Virgen de la Victoria
R. G. Maki - University of Pennsylvania
H. Martinez-Said - Instituto Alexander Fleming
J. L. Martinez-Tlahuel - Instituto Nacional de Cancerología
C. A. Mello
J. M. Morales Pérez
D. S. Moura - Hospital Universitario Virgen del Rocío
S. A. Nakagawa - Instituto Nacional de Enfermedades Neoplásicas
A. G. Nascimento - Hospital Clínico Universitario Virgen de la Victoria
E. J. Ortiz-Cruz - Hospital Universitario La Paz
S. Patel - University of Padua
Y. Pfluger - Ministerio de Agricultura y Ganadería de Costa Rica
S. Provenzano - University of Padua
A. Righi - Istituto Ortopedico Rizzoli
A. Rodriguez - Instituto Alexander Fleming
T. G. Santos
K. Scotlandi - Istituto Ortopedico Rizzoli
Silva Mlg - AC Camargo Hospital
T. Soulé - University of Padua
S. Stacchiotti - University of Padua
C. M. Valverde
F. Waisberg - AC Camargo Hospital
E. Zamora Estrada
J. Martin-Broto - Ministerio de Agricultura y Ganadería de Costa Rica
Publication Details: Critical reviews in oncology/hematology, Vol.174, p.103685
Publisher: The Authors. Published by Elsevier B.V; Netherlands
Number of pages: 10
Grant note: EU Horizon 2020 research and innovation programme: 825806 H2020 Societal Challenges Programme: 825806
The authors would like to thank the SELNET project, which has received funding from the EU Horizon 2020 research and innovation programme (grant number 825806).
Comment: LR: 20221011; LID: S1040-8428(22)00109-3 [pii]; CI: Copyright © 2022; JID: 8916049; EIN: Crit Rev Oncol Hematol. 2022 Dec;180:103827. doi: 10.1016/j.critrevonc.2022.103827. PMID: 36220678; OTO: NOTNLM; 2022/03/09 00:00 [received]; 2022/04/14 00:00 [revised]; 2022/04/14 00:00 [accepted]; 2022/04/24 06:00 [pubmed]; 2022/05/27 06:00 [medline]; 2022/04/23 20:10 [entrez]; AID: S1040-8428(22)00109-3 [pii]; ppublish
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 35460913
Record Identifier: 991032904112602976